Insights & Analysis
There’s one constant in healthcare: change. Count on us to break down the trends so you can stay up to date. Follow our take on each piece of this deep, intertwined, and often perplexing industry to find opportunities and practical approaches to move healthcare forward.
Featured Content
Premium Content
Premium Content
FasterCures Commits Seed Funding for Phase 2 of Patient-Perspective Value Framework (PPVF) Initiative
This week, FasterCures provided Avalere with a second round of seed funding to test, refine, and validate the PPVF.
Avalere’s Take on the Market Stabilization Final Rule
Today, the Centers for Medicare & Medicaid Services (CMS) released its final rule for market stabilization of the health insurance exchanges, following the departure of some health plans from the marketplace for the upcoming plan year.
Scott Peterson Joins Avalere as Vice President of Data Architecture
Scott Peterson, formerly Chief Information Officer at the Minnesota Department of Human Services, is joining Avalere’s Data Analytics and Development team.
Manufacturer’s Compassionate Use Policies: Companies with Posted Policies More Than Doubled Since September 2016
The 21st Century Cures Act requirement to post compassionate use policies may explain increase.
Final Report: The Impact of Medicare Advantage Data Submission System on Risk Scores
Avalere analyzed data from eight Medicare Advantage Organizations (MAOs) representing 1.1 million beneficiaries in more than 30 unique plans operating across the country to understand the impact of shifting the determination of plan risk scores from the traditional Risk Adjustment Processing System (RAPS) to the new Encounter Data System (EDS).
FDA Priority Review Voucher Programs: Incentive for Industry to Develop Novel Treatments
Extension of the Sunset Clause provides additional opportunity for the FDA to award vouchers and for transference of vouchers from recipients to other sponsors.
Risk-Bearing ACOs Growing in Popularity Under Medicare Programs
On January 18, 2017, the Centers for Medicare & Medicaid Services (CMS) announced the new Accountable Care Organization (ACO) participants in the Medicare Shared Savings Program (MSSP) for 2017.
Avalere’s Take on the ACA Market Stabilization Rule
Today, the Trump administration released a proposed rule for market stabilization of the Affordable Care Act (ACA).
Initial Analysis of ICER’s Value Framework Update
Today, the Institute for Clinical and Economic Review (ICER) released an updated version of its Value Assessment Framework.
Advancing Oncology Care Quality in the Era of Immuno-Oncology and Other Evolving Treatments
In June 2016, Avalere in collaboration with the American Society of Clinical Oncology, Cancer Support Community, Community Oncology Alliance, and Patient Advocate Foundation, and with support from Bristol-Myers Squibb, brought together a variety of healthcare stakeholders in a national Dialogue to discuss challenges and opportunities surrounding the advancement of quality in cancer care.
Promoting Shared Decision Making Around Costs to Improve Value
Avalere and the Robert Wood Johnson Foundation Launch Eight Grants to Improve Cost-of-Care Conversations Between Patients and Clinicians.
Avalere Releases Healthcare Industry Trends Report for 2017
This year will be the start of major environmental changes for the healthcare industry following a shift in the balance of power in Washington, DC, and the states.
Christie Teigland, PhD, Appointed to PQA Panel
Avalere Vice President, Christie Teigland, PhD, was recently appointed to the Pharmacy Quality Alliance’s (PQA) Quality Metrics Expert Panel (QMEP) for a three-year term effective January 1, 2017.
Avalere Analysis on Final EPM Bundle Rule
Today, the Centers for Medicare & Medicaid Services took another step in shifting Medicare to a value-based payment model that rewards hospitals for delivering better care at a lower cost.
Overview of Appropriate Use Criteria for Treating Knee Osteoarthritis
Earlier this year, Avalere led a work group of rheumatology, orthopedic surgery, psychiatry, sports medicine, and primary care clinicians to develop appropriate use criteria for the use of hyaluronic acid (HA) in the treatment of knee osteoarthritis (OA).
What You Need to Know About Today’s Cures Vote
Today, the House will vote on the updated version of the 21st Century Cures Act, H.R.34.
Deconstructing the Path to Innovation Adoption
During the last week of October, Avalere invited a select group of innovators to breakfasts in Los Angeles and San Francisco to discuss elements of successful adoption of innovative technologies and models of care.
Avalere Research Recently Published in Home Healthcare Journal
Avalere recently partnered with the Alliance for Home Health Quality and Innovation (AHHQI) to explore the topic of the future of home health care.
Releasing the Draft Avalere/FasterCures Patient-Perspective Value Framework (PPVF) for Public Input
Avalere and FasterCures released the first deliverable of the Patient-Perspective Value Framework (PPVF) Initiative at the annual Partnering for Cures Conference.
Election 2016 Results and Potential Implications
In addition to Donald Trump's presidential win earlier this week, Republicans also won big in the House and Senate.